HedgeChatter

  • Home /
  • Tag Archives

CRME

7:47 am Cardiome Pharma enters into an At Market Sales Issuance Agreement with MLV & Co. pursuant to which the co may from time to time sell common shares as would have an aggregate offer price of up to $30 mln

moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring next, click here to view […]

February 18, 2014 Bystocknews , Comments Off on 7:47 am Cardiome Pharma enters into an At Market Sales Issuance Agreement with MLV & Co. pursuant to which the co may from time to time sell common shares as would have an aggregate offer price of up to $30 mln read more

Cardiome Enters BRINAVESS Distribution Agreement With Nomeco A/S In Denmark

[PR Newswire] – VANCOUVER, Feb. 18, 2014 /PRNewswire/ – Cardiome Pharma Corp. (CRME) (COM.TO) today announced that its subsidiary, Correvio GmbH, has entered into an agreement with Nomeco A/S, headquartered in Copenhagen, Denmark, to distribute BRINAVESS moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring next, click here […]

February 18, 2014 Bystocknews , Comments Off on Cardiome Enters BRINAVESS Distribution Agreement With Nomeco A/S In Denmark read more

Cardiome Announces At-The-Market Offering

[PR Newswire] – VANCOUVER, Feb. 18, 2014 /PRNewswire/ – Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has entered into an At Market Sales Issuance Agreement with MLV & Co. LLC (MLV) pursuant to which the company may from time to moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to […]

February 18, 2014 Bystocknews , Comments Off on Cardiome Announces At-The-Market Offering read more

Cardiome’s BRINAVESS Demonstrates 74% Cardioversion in Post-Cardiac Surgery Patients with Atrial Fibrillation

[PR Newswire] – NASDAQ: CRME TSX: COM VANCOUVER, Feb. 13, 2014 /PRNewswire/ – Cardiome Pharma Corp. (NASDAQ: CRME) (TSX: COM) today announced that a poster titled Medical conversion with Vernakalant on postoperative … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring next, click here to view […]

February 13, 2014 Bystocknews , Comments Off on Cardiome’s BRINAVESS Demonstrates 74% Cardioversion in Post-Cardiac Surgery Patients with Atrial Fibrillation read more

Cardiome Enters Brinavess Distribution Agreement with Tamro AB in Sweden

[PR Newswire] – VANCOUVER, Feb. 11, 2014 /PRNewswire/ – Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that its subsidiary, Correvio GmbH, has entered into an agreement with Tamro AB, headquartered in Gothenburg, Sweden, to distribute BR moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring […]

February 11, 2014 Bystocknews , Comments Off on Cardiome Enters Brinavess Distribution Agreement with Tamro AB in Sweden read more

Cardiome Announces Share Consolidation Effective April 12, 2013

[at noodls] – Vancouver, Canada, April 12, 2013 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that effective as of the opening of trading on April 12, 2013, the Company’s share capital will begin trading … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring next, […]

April 12, 2013 Bystocknews , Comments Off on Cardiome Announces Share Consolidation Effective April 12, 2013 read more

Cardiome Appoints Jürgen Polifka, Ph.D., As General Manager, Sales And Marketing Europe

[at noodls] – Vancouver, Canada, April 2, 2013 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announces the addition of Dr. Jürgen Polifka, Ph.D., to its management team as General Manager, Sales and Marketing … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring next, click […]

April 2, 2013 Bystocknews , Comments Off on Cardiome Appoints Jürgen Polifka, Ph.D., As General Manager, Sales And Marketing Europe read more

Cardiome Announces The Addition Of Dr. Steen Juul-Möller As Medical Director, Europe

[at noodls] – Vancouver, Canada, March 28, 2013 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announces the addition of Steen Juul-Möller, M.D., Ph.D./DMSc., FESC to Cardiome’s management team as Medical … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring next, click here to view […]

March 28, 2013 Bystocknews , Comments Off on Cardiome Announces The Addition Of Dr. Steen Juul-Möller As Medical Director, Europe read more

Independent Proxy Advisor Firms ISS And Glass Lewis Recommend Cardiome Shareholders Vote in Favor Of Share Consolidation

[at noodls] – Vancouver, Canada, March 19, 2013 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Institutional Shareholder Services Inc. (ISS) and Glass Lewis & Co., two leading independent proxy … moreView todays social media effects on CRMEView the latest stocks trending across Twitter. Click to view dashboardSee who Cardiome is hiring next, click here to […]

March 19, 2013 Bystocknews , Comments Off on Independent Proxy Advisor Firms ISS And Glass Lewis Recommend Cardiome Shareholders Vote in Favor Of Share Consolidation read more